Esperion is to acquire Corstasis Therapeutics to expand its cardiovascular franchise with the addition of Enbumyst, a ...
Navigating uncertainty and building resilient supply chains: The case for US-based CDMO partnerships
Partnering with a US-based CDMO can offer many advantages for pharmaceutical companies looking to the US market.
Aspire Biopharma has partnered with Microsize to advance the development of a new sublingual powder formulation of alprazolam ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results